ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 762545 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 762545; 2) Community: the network communities that were significantly associated with the response to NSC 762545; 3) Molecule: the relationships between components within communities and NSC 762545; 4) MDR: the compounds that were significantly associated with the NSC 762545.

NSC Compound Enrichment Correlation
NSC 625499 Antimony, mu-iododiiodo[mu-(4-thiomorpholinecarbodi- thioato-S(4),S(4')]bis(4-thiomorpholinecarbodithioato-S(4), S(4'))di- 0.0401206532535668 -0.30024926
NSC 648154 Null 0.0401206532535668 0.059765313
NSC 678125 1H-indazole, 3-methoxy-1-[(2-methoxyphenyl)methyl]- 5-nitro- 0.0401206532535668 0.65275138
NSC 715135 Null 0.0401206532535668 0.57756229
NSC 716002 Null 0.0401206532535668 0.038483719
NSC 716261 Null 0.0401206532535668 0.6064429
NSC 748559 4-(4-chlorophenyl)-1-3-[(E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoyl]phenyl-2,3-dihydro-1H-2-imidazolone 0.0401206532535668 -0.0018169368
NSC 92207 Null 0.0401206532535671 -0.20954871
NSC 1011 P-[[.ALPHA.-(8-HYDROXY-7-QUINOLYL)BENZYL]AMINO]BENZOIC ACID 0.042089336762887 -0.15762435
NSC 174121 Methotrexate Derivative 0.042089336762887 -0.44603915
Total:56  Current:47    [First] [Prev] [Next] [Last]